Abstract
Ultrasound contrast agents (UCAs) have a well-established role in clinical cardiology. Contrast echocardiography has evolved into a routine technique through the establishment of contrast protocols, an excellent safety profile, and clinical guidelines which highlight the incremental prognostic utility of contrast enhanced echocardiography. This document aims to provide practical guidance on the safe and effective use of contrast; reviews the role of individual staff groups; and training requirements to facilitate its routine use in the echocardiography laboratory.
Original language | English |
---|---|
Article number | 23 |
Journal | Echo Research and Practice |
Volume | 10 |
Issue number | 1 |
DOIs | |
Publication status | Published - 15 Nov 2023 |
Externally published | Yes |
Bibliographical note
Funding Information:RH has received speaker fees from Bracco (Italy)and Lantheus Medical Imaging (Boston). RS has received speaker fees from Bracco (Italy), Lantheus (Boston), GE and Philips. HB has received consulting fees from Lantheus and research grants, honorarium for presentation at Bracco sponsored workshop. AK has received speaker fees from TomTec Imaging Systems and GmbH for educational workshops and webinars. PL acknowledges previous research grant support from Lantheus Medical Imaging. PL is a founder and shareholder of Ultromics, an echocardiography healthcare company.
Keywords
- Echocardiography
- Guideline
- Ultrasound contrast agents
ASJC Scopus subject areas
- Radiological and Ultrasound Technology
- Radiology Nuclear Medicine and imaging
- Advanced and Specialised Nursing